Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of $0.06. Revenue for the quarter came in at $62.5 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.